Karuna Therapeutics CEO Steven Paul's 2020 pay slips 11% to $8.9M
Karuna Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 27, 2021
Karuna Therapeutics reported fiscal year 2020 executive compensation information on April 27, 2021.
In 2020, four executives at Karuna Therapeutics received on average a compensation package of $5.2M, a 54% increase compared to previous year.
Average pay of disclosed executives at Karuna Therapeutics
Steven Paul, Chief Executive Officer, received $8.9M in total, which decreased by 11% compared to 2019. 90% of Paul's compensation, or $8M, was in option awards. Paul also received $288K in non-equity incentive plan, $575K in salary, as well as $8.6K in other compensation.
Andrew Miller, Chief Operating Officer, received a compensation package of $4.7M, which increased by 222% compared to previous year. 86% of the compensation package, or $4M, was in option awards.
Troy Ignelzi, Chief Financial Officer, earned $3.8M in 2020, a 298% increase compared to previous year.
Stephen Brannan, Chief Medical Officer, received $3.5M in 2020, which increases by 239% compared to 2019.
Related executives
You may also like
Source: SEC filing on April 27, 2021.